Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

6.280 -0.290 (-4.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,044
Open 6.540
Bid (Size) 6.020 (1)
Ask (Size) 6.790 (1)
Prev. Close 6.570
Today's Range 6.280 - 6.650
52wk Range 4.500 - 11.46
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
WHY: NEW YORK, NY - (NewMediaWire) - May 10, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
-1.57%
-1.57%
1 Month
+7.35%
+7.35%
3 Month
-26.55%
-26.55%
6 Month
-10.29%
-10.29%
1 Year
-26.55%
-26.55%

More News

Read More
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm, P.A.
Via Business Wire
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.